Rx Drug Promotion and the Clear, Conspicuous, and Neutral Final Rule
1:00:24
Introduction to FDA’s Office of Trade and Global Partnerships
24:17
FDA Direct, Ep. 5: What's the Deal with Talc? - Recapping
28:16
FDA Animal Biotechnology Case Study: Low-Risk Intentional Genomic Alteration in Animals for Food Use
35:55
OCE Project Catalyst Bench to Bedside Chat on the S 9 Guidance Document
45:29
FDA Drug Topic Webinar - Bad Ad Program
18:36
FDA Direct, Ep. 3: Striking a Balance - Framework for Future Covid-19 Vaccine Decisions
47:58
Model Master Files: Advancing Modeling/Simulation in Generic Drug Development/Regulatory Submissions
30:24